Journal
NATURE MEDICINE
Volume 17, Issue 6, Pages 684-U73Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2388
Keywords
-
Funding
- US National Institutes of Health (NIH) [AR53237]
- Public Health Service [UL 1RR025761-02]
- NIH [GM74241, AR053293]
- Leukemia and Lymphoma Society
- Van Andel Research Institute
Ask authors/readers for more resources
The human skeleton is affected by mutations in low-density lipoprotein receptor-related protein 5 (LRP5). To understand how LRP5 influences bone properties, we generated mice with osteocyte-specific expression of inducible Lrp5 mutations that cause high and low bone mass phenotypes in humans. We found that bone properties in these mice were comparable to bone properties in mice with inherited mutations. We also induced an Lrp5 mutation in cells that form the appendicular skeleton but not in cells that form the axial skeleton; we observed that bone properties were altered in the limb but not in the spine. These data indicate that Lrp5 signaling functions locally, and they suggest that increasing LRP5 signaling in mature bone cells may be a strategy for treating human disorders associated with low bone mass, such as osteoporosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available